The novel butyrate derivative phenylalanine-butyramide protects from doxorubicin-induced cardiotoxicity

Antineoplastic Drug-Induced Cardiotoxicity: A Redox Perspective

(2018) Gilda Varricchi et al.   Frontiers in Physiology

Left Ventricular Dysfunction in Cancer Treatment

(2018) Benjamin Kenigsberg et al.   JACC-Heart Failure

Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline

(2017) Saro H. Armenian et al.   JOURNAL OF CLINICAL ONCOLOGY

An orally administered butyrate-releasing derivative reduces neutrophil recruitment and inflammation in dextran sulphate sodium-induced murine colitis

(2016) Raffaele Simeoli et al.   BRITISH JOURNAL OF PHARMACOLOGY

Linking the Human Gut Microbiome to Inflammatory Cytokine Production Capacity

(2016) Melanie Schirmer et al.   CELL

Chemical Endoplasmic Reticulum Chaperone Alleviates Doxorubicin-Induced Cardiac DysfunctionNovelty and Significance

(2016) Hai Ying Fu et al.   CIRCULATION RESEARCH

2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines

(2016) Jose Luis Zamorano et al.   EUROPEAN JOURNAL OF HEART FAILURE

Sodium butyrate and its synthetic amide derivative modulate nociceptive behaviors in mice

(2016) Roberto Russo et al.   PHARMACOLOGICAL RESEARCH

Histone deacetylases as therapeutic targets — From cancer to cardiac disease

(2015) Alon Abend et al.   PHARMACOLOGY & THERAPEUTICS

Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron

(2014) Tomáš Šimůnek et al.   Pharmacological Reports

Anthracyclines and Heart Failure

(2013) Douglas B. Sawyer   NEW ENGLAND JOURNAL OF MEDICINE

Intestinal Microbial Metabolism of Phosphatidylcholine and Cardiovascular Risk

(2013) W.H. Wilson Tang et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effects of Sodium Butyrate and Its Synthetic Amide Derivative on Liver Inflammation and Glucose Tolerance in an Animal Model of Steatosis Induced by High Fat Diet

(2013) Giuseppina Mattace Raso et al.   PLoS One

Oxidative Stress, Redox Signaling, and Metal Chelation in Anthracycline Cardiotoxicity and Pharmacological Cardioprotection

(2012) Martin Štěrba et al.   ANTIOXIDANTS & REDOX SIGNALING

A histone deacetylase inhibitory prodrug – Butyroyloxymethyl diethyl phosphate – Protects the heart and cardiomyocytes against ischemia injury

(2012) G. Kessler-Icekson et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Identification of the molecular basis of doxorubicin-induced cardiotoxicity

(2012) Sui Zhang et al.   NATURE MEDICINE

Diet induced epigenetic changes and their implications for health

(2011) J. A. McKay et al.   Acta Physiologica

Anthracycline cardiotoxicity

(2011) Pierantonio Menna et al.   Expert Opinion On Drug Safety

Nitric Oxide/Reactive Oxygen Species Generation and Nitroso/Redox Imbalance in Heart Failure: From Molecular Mechanisms to Therapeutic Implications

(2010) Chiara Nediani et al.   ANTIOXIDANTS & REDOX SIGNALING

The histone deacetylase inhibitor butyroyloxymethyl diethylphosphate (AN-7) protects normal cells against toxicity of anticancer agents while augmenting their anticancer activity

(2010) Nataly Tarasenko et al.   INVESTIGATIONAL NEW DRUGS

Mitochondrial pathways for ROS formation and myocardial injury: the relevance of p66Shc and monoamine oxidase

(2009) Fabio Di Lisa et al.   BASIC RESEARCH IN CARDIOLOGY